Dr. Reddy's Laboratories Ltd. Financials: Quarterly Results
Revenue
8995.8
Cr.
PAT
1187.30
Cr.
EBITDA
1635.30
Cr.
Dr. Reddy's Laboratories Ltd. Q3FY26 Financial Metrics
| Indicator | Dec-25 | Sep-25 | Jun-25 | Mar-25 | Dec-24 |
|---|---|---|---|---|---|
| Net Sales/Income from operations (Cr.) | 8727 | 8804.90 | 8545.20 | 8506 | 8381.20 |
| Total Income From Operations (Cr.) | 8753.40 | 8828.30 | 8572.10 | 8528.40 | 8381.20 |
| P/L Before Interest, Excpt. Items & Tax (Cr.) | 1635.30 | 1829.20 | 1987.80 | 2065.30 | 1951.80 |
| P/L Before Exceptional Items & Tax (Cr.) | 1540.90 | 1738.50 | 1904.80 | 1999.70 | 1870.10 |
| P/L After Tax from Ordinary Activities (Cr.) | 1187.30 | 1330.50 | 1409.70 | 1581.20 | 1400 |
| Net Profit/Loss For the Period (Cr.) | 1187.30 | 1330.50 | 1409.70 | 1581.20 | 1400 |
| Basic EPS | 14.53 | 16.18 | 17.04 | 19.12 | 16.97 |
FAQs
Dr. Reddy's Laboratories Ltd. announced its quarterly results for Q3 FY2026 on January 21, 2026.
In Q3 FY2026, Dr. Reddy's Laboratories Ltd. are as follows:
Revenue: ₹8995.8 crore
Net Profit: ₹1187.30 crore.
For Q3 FY2026, Dr. Reddy's Laboratories Ltd. posted ₹8995.8 crore in revenue and ₹1187.30 crore in net profit.
Past quarterly results for Dr. Reddy's Laboratories Ltd. can be found on their official Investor Relations page, which includes detailed reports and financial performance summaries.